Navidea Biopharmaceuticals Inc (NAVB)
0.036
0.00 (0.00%)
USD |
OTCM |
Apr 30, 15:30
Navidea Biopharmaceuticals Net Income (Quarterly): -2.255M for Sept. 30, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -2.255M |
| June 30, 2023 | 6.032M |
| March 31, 2023 | -1.476M |
| December 31, 2022 | -3.483M |
| September 30, 2022 | -5.708M |
| June 30, 2022 | -3.000M |
| March 31, 2022 | -2.987M |
| December 31, 2021 | -3.652M |
| September 30, 2021 | -2.438M |
| June 30, 2021 | -2.674M |
| March 31, 2021 | -2.967M |
| December 31, 2020 | -2.823M |
| September 30, 2020 | -2.899M |
| June 30, 2020 | -2.326M |
| March 31, 2020 | -2.674M |
| December 31, 2019 | -2.772M |
| September 30, 2019 | -3.074M |
| June 30, 2019 | -2.673M |
| March 31, 2019 | -2.429M |
| December 31, 2018 | -3.160M |
| September 30, 2018 | -3.822M |
| June 30, 2018 | -2.394M |
| March 31, 2018 | -6.738M |
| December 31, 2017 | -4.058M |
| September 30, 2017 | -1.390M |
| Date | Value |
|---|---|
| June 30, 2017 | -5.188M |
| March 31, 2017 | 85.58M |
| December 31, 2016 | -3.882M |
| September 30, 2016 | -0.0594M |
| June 30, 2016 | -6.681M |
| March 31, 2016 | -3.686M |
| December 31, 2015 | -2.510M |
| September 30, 2015 | -8.071M |
| June 30, 2015 | -9.691M |
| March 31, 2015 | -7.291M |
| December 31, 2014 | -6.865M |
| September 30, 2014 | -6.899M |
| June 30, 2014 | -10.22M |
| March 31, 2014 | -11.74M |
| December 31, 2013 | -13.75M |
| September 30, 2013 | -11.31M |
| June 30, 2013 | -10.30M |
| March 31, 2013 | -7.341M |
| December 31, 2012 | -7.235M |
| September 30, 2012 | -9.099M |
| June 30, 2012 | -5.835M |
| March 31, 2012 | -6.989M |
| December 31, 2011 | -7.608M |
| September 30, 2011 | 19.83M |
| June 30, 2011 | -2.189M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-5.708M
Minimum
Sep 2022
6.032M
Maximum
Jun 2023
-2.436M
Average
-2.798M
Median
Net Income (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -24.68M |
| Electromed Inc | 1.674M |
| Xtant Medical Holdings Inc | -4.303M |
| Asensus Surgical Inc | -17.24M |
| Senseonics Holdings Inc | -17.19M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.131M |
| EPS Diluted (Quarterly) | -0.02 |
| Enterprise Value | 1.180M |
| Earnings Yield | -166.7% |
| Normalized Earnings Yield | -1555.56 |